HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

L’Oreal’s Winning Continues In Q3; Now To Fix ‘Only Weakness In The Picture’

Executive Summary

Makeup softness isn’t the problem, per se, in L’Oreal’s sluggish US business, which is fixable with sharper innovation and execution driven by a newly instated leadership team, CEO Jean-Paul Agon says. L’Oreal’s overall global sales in fiscal 2019 to date are up 7.5%, like-for-like, after continued strong momentum in its fiscal 2019 third quarter.

You may also be interested in...



Beauty Market News: China Cosmetics Regulations Modernized, Florida Stops Local Oxybenzone Bans, More

L’Oreal acquires Thayers Natural Remedies; Unilever, L’Oreal remove ‘whitening,’ ‘fair’ from labels; China finalizes modernization of cosmetics regulations; and Florida governor signs law preventing local bans on oxybenzone.

Old Dog, New Tricks: L’Oreal’s Fiscal 2019 Shows Best Growth Since 2007

L’Oreal is not only learning new tricks in today’s digital world but continuing to outpace the competitive pack, with sales up double digits in fiscal 2019 to €29.9bn.

Lauder Defies Specter Of China, Travel Retail Slowdowns, Raises FY 2020 Sales Targets

Lauder is responding to shifting trends with greater agility than ever while leveraging enhanced data analytics and consumer insight to innovate ahead of the curve, leadership says. Following 11% constant-currency growth in the fiscal 2020 first quarter, the firm is forecasting 8% to 9% net sales gains for the full year.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel